Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia
Insulin degludec/insulin aspart (IDegAsp) co-formulation provides both basal and mealtime glycaemic control in a single injection. The glucose level-lowering efficacy of IDegAsp is reported to be superior or non-inferior to that of the currently available insulin therapies with a lower rate of overa...
Main Authors: | Siew Pheng Chan, Malik Mumtaz, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Siang Chin Lim, Azhari Rosman, Kok Han Chee, Soo Kun Lim, Shiong Shiong Yew, Barakatun-Nisak Mohd Yusof, Bik Kui Lau, Saiful Bahari Kassim, Mafauzy Mohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Family Physicians of Malaysia
2023-05-01
|
Series: | Malaysian Family Physician |
Subjects: | |
Online Access: | https://e-mfp.org/wp-content/uploads/18.31R1CPGPracticalguideinusinginsulindegludec.pdf |
Similar Items
-
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
by: Sanjay Kalra, et al.
Published: (2016-01-01) -
Insulin degludec aspart: One-year real world experience
by: Sanjay Kalra, et al.
Published: (2016-01-01) -
Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
by: Qiong Luo, et al.
Published: (2022-10-01) -
Hypoglycemia in Type 2 Diabetes Patients Substituted with Insulin Degludec Aspart from Premixed Insulin Therapy: a Quasi Experimental Study
by: Komal Mumtaz Malik, et al.
Published: (2024-04-01) -
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)